5th Annual Diabetes, Obesity, & Metabolic Disease Conference
5th Annual Diabetes, Obesity, & Metabolic Disease Conference is organized by Continuing Education Company, Inc. (CEC) and will be held from Apr 17 - 19, 2020 at Sheraton New Orleans Hotel, New Orleans, Louisiana, United States of America.
This conference is designed for primary care physicians, nurse practitioners, physician assistants, and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic disorders.
AAFP: This live activity, 4th Annual Diabetes, Obesity, & Metabolic Disease Conference, with a beginning date of April 17, 2020 has been reviewed and is acceptable for up to 15.00 Prescribed credit(s) by the American Academy of Family Physicians.
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. (CEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
CFPC: Members of the College of Family Physicians of Canada are eligible to receive 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
Cardiometabolic disorders are a cluster of health conditions associated with cardiovascular disease and type 2 diabetes. It is estimated that over 1/3 of American’s suffer from a cardiometabolic disorder. The associated morbidity and mortality deserve increased clinical attention as we address risk factors predisposing individuals to these disorders. This program will help identify these conditions and their related complications to enable clinicians to appropriately intervene with evidence-based treatments and risk-factor control while improving patient education.
As a result of this conference, participants will be able to:
• Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
• Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
• Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
|Contact No. :||(800) 327-4502
|Registration Type||Last Date||Price|
|MD - Conference Fee||17 Apr,2020||USD 655.00|
|NP, PA and Others - Conference Fee||17 Apr,2020||USD 610.00|